Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1995-06-05
1998-05-26
Feisee, Lila
Chemistry: molecular biology and microbiology
Spore forming or isolating process
5303873, 53038823, 5303883, 53038885, 5303892, 4352402, 4241411, 4241581, C12N 512, C07K 1608, A61K 39395
Patent
active
057563420
ABSTRACT:
A method of treating EBV infections is provided. The method comprises administering an effective amount of an monoclonal antibody antagonist to the EBV protein, BCRF1. Preferably, the antagonist is a blocking monoclonal antibody specific for BCRF1, or a fragment or binding composition derived therefrom.
REFERENCES:
patent: 5231012 (1993-07-01), Mosmann et al.
Seaver, Genetic Engineering News 14:10,21 1994.
Hams et al., Tibtech 11:42-44, 1993.
Casali et al., Science 234:476-479, 1986.
Baer et al., "DNA seuence and expression of the b95-8 Epstein-Barr virus genome," Nature 310:207-211 (Jul. 1984).
Bean et al., "Interleukin 10 protects mice against staphylococcal enterotoxinB-induced lethal shock," Infection and Immuity 61(10):4937-4939 (1993).
de Waal Malefyt et al., "Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes," J. Exp. Med. 174:1209-1220 (1991).
Fiorentino et al., "Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones," Journal of Experimental Medicine 170:2081-2095 (1989).
Fiorentino et al,. "IL-10 inhibits cytokine production by activated macrophages," The Journal of Immunology 147(11):3815-3822 (1991).
Go et al., "Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells," Journal of Experimental Medicine 172(6):1625-1631 (1990).
Hirsch, "Herpesvirus infections," Scientific American Medicine 2(Chapter XXVI):1-11 (Oct. 1992).
Horowitz et al., "Autocrine growth inhibition of a cloned line of helper T cells," Proc. Natl. Acad. Sci. USA 83:1886-1890 (1986).
Howard et al., "Interleukin 10 protects mice from lethal endotoxemia," J. Exp. Med. 177:1205-1211 (1993).
Hsu et al., "differential effects of IL-4 and IL-10 on IL-2 induced IFN-.gamma. synthesis and lumphokine-activated killer activity," J. of Immunol. 6:663-663 (1992).
Hsu, "Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1," Science 250:830-832 (Nov. 1990).
Hudson et al., "The short unique region of the B95-8 Epstein-Barr virus genome," Virology 147:81-98 (1985).
International Search Report from corresponding application (Jul. 1991).
Joakim Dillner et al., "The Epstein-Barr virus proteins," Advances in Cancer Research 50:95-158 (1988).
Kohler et al., "Continuous cultures of fused cells secreting antibody of predefined specificity," Nature 256:495-497 (Aug. 1975).
Marchant et al., "Interleukin-10 controls interferon-.gamma. and tumor necrosis factor production during experimental endotoxemia," Eur. J. Immunol. 24:1167-1171 (1994).
McDevitt, "The molecular basis of autoimmunity," Clinical Research 34:163-175 (1985).
Moore et al., "Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI," Science 248:1230-1234 (Jun. 1990).
Schooley et al., "Epstein-Barr virus (infectious mononucleosis)," Principles and Practice of Infectious Disease, second ed., John Wiley & Sons, Chapter 126, pp. 971-979 (1985).
Swaminathan et al., "Epstein-Barr virus recombinants with specifically mutated BCRF1 genes," Journal of Virology 67(2):7406-7413 (1993).
Thorley-Lawson, "Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases," Biochimica et Biophysical Acta, 948:263-286 (1988).
Tosato, "The Epstein-Barr virus and the immune system," Advances in Cancer Research, 49:75-125 (1987).
Vieiera et al., "Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Expstein-Barr virus open reading frame BCRF1," Proc. Natl. Acad. Sci. USA 88:1172-1176 (1991).
von Heijne, "A new method for predicting signal sequence cleavage sites," Nucleic Acids Research 14(11):4683-4690 (1986).
Waldmann, "Monoclonal antibodies in diagnosis and therapy," Science, 252:1657-1662 (Jun. 1991).
Albert Zlotnik, et al., "Effects of IL-10 in Lipopolysaccharide- and Superantigen-Induced Lethal Shock in Vivo", Molecular Biology Intelligence Unit - Interleukin 10, Chapter 13, pp. 121-126 (1995).
Apple Randolph T.
Dow Karen B.
Feisee Lila
Johnson Nancy A.
Macevicz Stephen C.
LandOfFree
BCRF1 antagonists for treating epstein-barr virus infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with BCRF1 antagonists for treating epstein-barr virus infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BCRF1 antagonists for treating epstein-barr virus infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1959140